检索

期
标题
作者
编号 5 (2013)
Correction of erectile dysfunction in patients with BPH using daily administration of tadalafil 5 mg against the background of combined drug. therapy
Volkov A., Petrichko M., Budnik N.
PDF
(Rus)
编号 2 (2013)
TADALAFIL IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA DURING CONSERVATIVE COMBINED THERAPY
Volkov A., Petrichko M., Budnik N., Dukhin A.
PDF
(Rus)
编号 6 (2009)
Effektivnost', bezopasnost' i perspektivy dlitel'nogo ispol'zovaniya tadalafila v rezhime odin raz v den' u patsientov s erektil'noy disfunktsiey
Zhivov A.
编号 4 (2019)
EFFICIENCY OF PHOSPHODIESTERASE-5 INHIBITORS FOR TREATMENT OF LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND CONCOMITANT ERECTILE DYSFUNCTION
Kamalov A., Nizov A.
PDF
(Rus)
编号 5 (2009)
Vozmozhnosti terapii erektil'noy disfunktsii neyrogennogo geneza ingibitorami fosfodiesterazy 5-go tipa u bol'nykh sakharnym diabetom
Kurbatov D., Rozhivanov R.
编号 1 (2019)
Safety of tadalafil in patients with cardiovascular comorbidities
Nikitina I., Gaysina G., Galimov S., Bulygin K., Galimova E., Pavlov V.
PDF
(Rus)
编号 2 (2018)
The role of tadalafil in the management of sexual dysfunctions
Efremov E., Kasatonova E., Melnik Y., Nikushina A.
PDF
(Rus)
编号 1 (2017)
PHOSPHODIESTERASE TYPE 5 INHIBITORS IN THE TREATMENT OF ERECTILE DYSFUNCTION: PAST, PRESENT AND FUTURE
Gamidov S., Ovchinnikov R., Popova A., Izhbaev S.
PDF
(Rus)
编号 4 (2014)
Daily intake of phosphodiesterase type 5 inhibitors - correction of erectile dysfunction and lower urinary tract symptoms in patients with bph
Volkov A., Petrichko M., Budnik N.
PDF
(Rus)
1 - 9 的 9 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##